DAPAGLIFLOZIN USE IN HFREF PATIENTS: A SINGLE CENTRE COMPARISON BETWEEN REAL-LIFE AND DAPA-HF DATA

被引:0
|
作者
Mapelli, M.
Capovilla, T.
Mattavelli, I.
Salvioni, E.
Marongiu, A.
Maranzano, G.
Paganin, C.
Vignati, C.
Palermo, P.
Sinagra, G.
Agostoni, P.
机构
[1] IRCCS, Ctr Cardiol Monzino, Milan, Italy
[2] Univ Trieste, Azienda Sanit Univ Giuliano Isontina ASUGI, Dept Cardiothoracovasc, Trieste, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P216
引用
收藏
页数:2
相关论文
共 50 条
  • [1] DAPAGLIFLOZIN USE IN HEART FAILURE WITH REDUCED EJECTION FRACTION PATIENTS: A SINGLE CENTRE COMPARISON BETWEEN REAL-LIFE AND DAPA-HF DATA
    Capovilla, Teresa Maria
    Mapelli, Massimo
    Mattavelli, Irene
    Salvioni, Elisabetta
    Marongiu, Alessandro
    Maranzano, Gaspare
    Vignati, Carlo
    Palermo, Pietro
    Sinagra, Gianfranco
    Agostoni, Piergiuseppe
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24
  • [2] Effect of Dapagliflozin in Patients With HFrEF Treated With Sacubitril/Valsartan The DAPA-HF Trial
    Solomon, Scott D.
    Jhund, Pardeep S.
    Claggett, Brian L.
    Dewan, Pooja
    Kober, Lars
    Kosiborod, Mikhail N.
    Martinez, Felipe A.
    Ponikowski, Piotr
    Sabatine, Marc S.
    Inzucchi, Silvio E.
    Desai, Akshay S.
    Bengtsson, Olof
    Lindholm, Daniel
    Sjostrand, Mikaela
    Langkilde, Anna Maria
    McMurray, John J., V
    JACC-HEART FAILURE, 2020, 8 (10) : 811 - 818
  • [3] Dapagliflozin in HFrEF Patients Treated With Mineralocorticoid Receptor Antagonists An Analysis of DAPA-HF
    Shen, Li
    Kristensen, Soren Lund
    Bengtsson, Olof
    Bohm, Michael
    de Boer, Rudolf A.
    Docherty, Kieran F.
    Inzucchi, Silvio E.
    Katova, Tzvetana
    Kober, Lars
    Kosiborod, Mikhail N.
    Langkilde, Anna Maria
    Lindholm, Daniel
    Martinez, M. Felipe A.
    O'Meara, Eileen
    Nicolau, Jose C.
    Petrie, Mark C.
    Ponikowski, Piotr
    Sabatine, Marc S.
    Schou, Morten
    Sjostrand, Mikaela
    Solomon, Scott D.
    Jhund, Pardeep S.
    McMurray, John J. V.
    JACC-HEART FAILURE, 2021, 9 (04) : 254 - 264
  • [4] CA125 IN PATIENTS WITH HFREF AND THE EFFECT OF DAPAGLIFLOZIN: INSIGHTS FROM DAPA-HF
    McMurray, John J. V.
    Docherty, Kieran F.
    Welsh, Paul
    Anand, Inderjit S.
    Berg, David
    De Boer, Rudolf A.
    Jarolim, Petr
    Kober, Lars
    Kosiborod, Mikhail
    Martinez, Felipe A.
    O'Meara, Eileen
    Morrow, David A.
    Ponikowski, Piotr
    Sabatine, Marc Steven
    Sattar, Naveed
    Schou, Morten
    Hammarstedt, Ann
    Langkilde, Anna Maria
    Sjoestrand, Mikaela
    Solomon, Scott D.
    Jhund, Pardeep
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 618 - 618
  • [5] Interleukin-6 in Patients With HFrEF and the Effect of Dapagliflozin: Insights From DAPA-HF
    Docherty, Kieran
    Welsh, Paul
    Anand, Inder S.
    Berg, David
    De Boer, Rudolf A.
    Kober, Lars
    Kosiborod, Mikhail N.
    Martinez, Felipe
    OMeara, Eileen
    Morrow, David
    Petrie, Mark
    Ponikowski, Piotr
    Sabatine, Marc S.
    Schou, Morten
    Sattar, Naveed
    Hammarstedt, Ann
    Langkilde, Anna Maria
    Sjostrand, Mikaela
    Solomon, Scott
    Jhund, Pardeep S.
    McMurray, John J.
    CIRCULATION, 2023, 148
  • [6] The effect of dapagliflozin in patients with HFrEF and COPD: a post-hoc analysis of DAPA-HF
    Dewan, P.
    Jhund, P. S.
    Bengtsson, O.
    Demets, D. L.
    Inzucchi, S. E.
    Kober, L.
    Kosiborod, M. N.
    Langkilde, A. M.
    Lindholm, D.
    Martinez, F. A.
    Ponikowski, P.
    Sabatine, M. S.
    Sjostrand, M.
    Solomon, S. D.
    McMurray, J. J., V
    EUROPEAN HEART JOURNAL, 2020, 41 : 932 - 932
  • [7] CONSISTENT BENEFIT OF DAPAGLIFLOZIN ACCORDING TO BACKGROUND THERAPY IN PATIENTS WITH HFREF: AN ANALYSIS OF THE DAPA-HF TRIAL
    Docherty, Kieran
    Jackson, Alice
    Inzucchi, Silvio E.
    Jhund, Pardeep
    Kober, Lars
    Kosiborod, Mikhail
    Langkilde, Anna Maria
    Martinez, Felipe
    Bengtsson, Olof
    Ponikowski, Piotr
    Sabatine, Marc
    Sjoestrand, Mikaela
    Solomon, Scott D.
    Desai, Akshay S.
    Diez, Mirta
    Howlett, Jonathan
    Ljungman, Charlotta E. A.
    O'Meara, Eileen
    Petrie, Mark
    Schou, Morten
    Pham, Vinh
    McMurray, John
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 656 - 656
  • [8] EFFECT OF TREATMENT WITH DAPAGLIFLOZIN ACCORDING TO BASELINE SYSTOLIC BLOOD PRESSURE IN PATIENTS WITH HFREF: AN ANALYSIS OF THE DAPA-HF TRIAL
    McMurray, John
    Boehm, Michael
    Serenelli, Matteo
    Inzucchi, Silvio E.
    Jhund, Pardeep
    Kober, Lars
    Kosiborod, Mikhail
    Langkilde, Anna Maria
    Martinez, Felipe
    Bengtsson, Olof
    Ponikowski, Piotr
    Sabatine, Marc
    Sjoestrand, Mikaela
    Solomon, Scott D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 849 - 849
  • [9] A real-world population with HFrEF treated with dapagliflozin or empagliflozin: a comparative analysis with DAPA-HF and EMPEROR REDUCED studies
    Mapelli, M.
    Mattavelli, I. Irene
    Salvioni, E.
    Caputo, R.
    Paganin, C.
    Nepitella, A.
    Campodonico, J.
    Vignati, C.
    Mantegazza, V.
    Garlasche, A.
    Nava, A.
    Piotti, A.
    Gugliandolo, P.
    Agostoni, P.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 206 - 207
  • [10] DAPAGLIFLOZIN IMPROVES OUTCOMES IRRESPECTIVE OF NT-PROBNP CONCENTRATION IN PATIENTS WITH HFREF: AN ANALYSIS OF THE DAPA-HF TRIAL
    Kober, Lars
    Docherty, Kieran
    Inzucchi, Silvio E.
    Jhund, Pardeep
    Kosiborod, Mikhail
    Langkilde, Anna Maria
    Martinez, Felipe
    Bengtsson, Olof
    Ponikowski, Piotr
    Sabatine, Marc
    Sjoestrand, Mikaela
    Solomon, Scott D.
    McMurray, John
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 675 - 675